HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Time- and dose-dependent induction of invasive urinary bladder cancers by N-ethyl-N-(4-hydroxybutyl)nitrosamine in B6C3F1 mice.

Abstract
A sequential investigation of N-ethyl-N-(4-hydroxybutyl)nitrosamine (EHBN) bladder carcinogenesis was performed in male B6C3F1 mice maintained ad libitum on tap water containing 0.025% EHBN for 4, 12, 20, 28 and 36 weeks. A total of 81 invasive tumors, comprising 55 squamous cell carcinomas (SCCs) (68%), 25 transitional cell carcinomas (TCCs) (31%) and 1 adenocarcinoma (1%) were found. Of these, 23 (22 SCCs and 1 TCC) demonstrated invasion to the prostate, 3 metastasized to the lung, and 2 spread by peritoneal seeding. The anaplastic grade and extent of invasion of the SCCs significantly exceeded those of the TCCs. The results suggested a histogenetic pathway from simple dysplasia through papillary or nodular dysplasia and/or carcinoma in situ to eventual development of invasive carcinomas.
AuthorsS Tamano, A Hagiwara, E Suzuki, M Okada, T Shirai, S Fukushima
JournalJapanese journal of cancer research : Gann (Jpn J Cancer Res) Vol. 82 Issue 6 Pg. 650-6 (Jun 1991) ISSN: 0910-5050 [Print] Japan
PMID1906851 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Carcinogens
  • Butylhydroxybutylnitrosamine
  • N-ethyl-N-(4-hydroxybutyl)nitrosamine
Topics
  • Animals
  • Butylhydroxybutylnitrosamine (analogs & derivatives, toxicity)
  • Carcinogens (toxicity)
  • Carcinoma in Situ (chemically induced, pathology)
  • Carcinoma, Squamous Cell (chemically induced, pathology)
  • Carcinoma, Transitional Cell (chemically induced, pathology)
  • Dose-Response Relationship, Drug
  • Epithelium (drug effects, pathology, ultrastructure)
  • Male
  • Mice
  • Mice, Inbred Strains
  • Neoplasm Invasiveness
  • Time Factors
  • Urinary Bladder (drug effects, pathology)
  • Urinary Bladder Neoplasms (chemically induced, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: